This study will test if a new software program called EpiPredict can predict which biologic therapy might work best for treating Crohn’s disease (CD). This study will include about 378 participants from 6 countries in Europe, and about 98 participants in the United Kingdom (UK). EpiPredict will predict how well two biologics for CD (vedolizumab and ustekinumab) will work. Both vedolizumab and ustekinumab are approved for use in people with CD as part of their usual care. This study is testing if ...

GO TO STUDY

CRYSTAL is an observational study whereby participants will attend one 4 ½ -hour visit at the Division of Cardiovascular Medicine,University of Oxford at the John Radcliffe Hospital in Oxford,with the option to split the study visit over two days for convenience. Participants will be recruited from the ALSPAC cohort (G0 mothers cohort),75 will have had a hypertensive pregnancy and 75 will have had a normotensive pregnancy. At time of follow-up,they will be 30-35 years post pregnancy. Of the G0 cohort,2237 ...

GO TO STUDY

Our aim is to see if palliative long-term abdominal drains (LTADs) result in better quality of life in patients with fluid in the belly due to liver scarring (cirrhosis), compared with current standard of care. The liver can be damaged by excessive alcohol and viral infections. If liver damage continues this scarring leads to permanent damage. It causes a painful buildup of fluid in the abdomen (ascites). Drugs can treat this, but may stop working, leading to ...

GO TO STUDY

GLO-Surgery is an open label,randomised,international,phase II clinical trial comparing fluorescence guided surgery (FGS) using Indocyanine Green (ICG) and near infra-red fluorescence (NIRF) to surgery using standard white light conditions.

GO TO STUDY

In a recently completed clinical trial funded by the NIHR, evaluating the effects of gene therapy in patients with early stage choroideremia, subsequent analysis the patients with a 'smooth zone' of central retinal autofluorescence indicated that the degeneration might been slowed. It appears that as the disease progresses, the smooth zone becomes mottled and then disappears completely with vision loss. We therefore believe that smooth zone analysis will be very helpful in a follow-on clinical trial. Before doing this, however, ...

GO TO STUDY

Following informed consent/consultee declaration,a member of the research will collect relevant clinical and demographic information from the participant and their clinical notes (e.g. age,gender,ethnicity,highest level of education,clinical diagnosis,month and year of stroke,previous strokes (yes/no),cognitive status). These will be recorded on the Trial Entry Form. Participants contact details and preferred mode of contact will also be recorded in the Trial Entry Form. The Trial Entry Form will be shared with the research team using the Microsoft OneDrive server link hosted by ...

GO TO STUDY

The overall aim of this study is to elucidate the molecular and cellular mechanisms underlying RSV-induced lung remodelling that contributes to the development of chronic lung disease such as asthma. This can be split into three objectives: 1. Comparison of RSV-induced responses in bronchial ALI cultures derived from asthmatic and non-asthmatic paediatric patients. 2. Determining secreted factors from RSV-infected bronchial ALI cultures that drive fibroblast-myofibroblast differentiation and fibrosis. 3. Transcriptomic analysis and comparison of bronchial cells from RSV-infected patients and bronchial ALI cultures from asthmatic ...

GO TO STUDY

Stroke due to intracerebral haemorrhage (ICH) is a devastating cardiovascular disease that causes 48% of disability-adjusted life years due to stroke. ICH survivors are at high risk of further major adverse cardiovascular or cerebrovascular events (MACE, i.e. hospitalisation due to stroke [ischaemic or ICH], hospitalisation due to myocardial infarction, or cardiovascular death [by ischaemia, bleeding or other vascular causes]). In the REstart or STop Antithrombotics Randomised Trial (RESTART) of 537 people with cardiovascular diseases who survived ICH in the UK, ...

GO TO STUDY

Maintaining adequate vision for safe driving is a common concern for people with diabetic eye disease. One of the typical treatments for severe levels of diabetic eye disease is panretinal photocoagulation (PRP) laser treatment. Although PRP laser has been shown to halve the risk of severe vision loss and help to stabilise diabetic eye disease in the long term, it causes laser scars that can affect peripheral vision. In addition to visual acuity standards (reading a number plate from 20m), ...

GO TO STUDY

The study will be a pragmatic,Phase IIIb,two-arm,double-blind randomised (1:1) placebo-controlled trial of ASUC patients admitted to UK National Health Service (NHS) hospitals. The study will recruit 300 patients admitted to hospital with suspected ASUC over ~30 months across up to 30 UK sites. Participant involvement in the study will depend on their response to IMP or placebo treatment. Screening,baseline assessment and randomisation will take place within 36 hours from the first dose of IV corticosteroids. The initial blinded IMP or placebo treatment ...

GO TO STUDY